Global View: ITC, Titan Company and Cadila Healthcare could yield 10-30% in 12 months
Indian market is likely to consolidate on Friday, tracking muted global cues, but there will be stock-specific action in which global brokerage came out with their reports on business development, or earnings outlook.
Indian market is likely to consolidate on Friday, tracking muted global cues, but there will be stock-specific action in which global brokerage came out with their reports on business development, or earnings outlook.
We have collated a list of recommendations from various global brokerage firms according to a Zee Business TV report:
ITC: Buy| Target Rs 285
CLSA maintained buy rating on ITC post December quarter results with a target price of Rs 285 that translates into an upside of over 21 per cent from 3 February.
ITC has seen a material top-line recovery, and the FMCG business delivered 9.3% top-line growth in Q3 which is a positive sign.
See Zee Business Live TV Streaming Below:
The global investment bank continues to see a K-shaped trajectory for the FMCG business. Capital allocation concerns are progressively being addressed which is positive.
Titan Company: Overweight| Target Rs 2720
Morgan Stanley maintained an overweight rating on Titan Company post December quarter results with a target price of Rs 2720 that translates into an upside of nearly 10 per cent from Rs 2479 recorded on 3 February.
The Q3 earnings beat Morgan Stanley's estimate and consensus by 16% and 13%. The December quarter performance was strong across all parameters, and the management sounded optimistic for the near term.
Cadila Healthcare: Overweight| Target Rs 543
Morgan Stanley upgraded Cadila Healthcare to overweight from equal weight post December quarter results but slashed the target price to Rs 543 from 664 earlier. The new target translates into an upside of over 30 per cent from Rs 408 recorded on 3 February.
The stock appears to be pricing in near-term challenges. Current valuations are ignoring mid-term opportunities.
The stock is trading at attractive valuations. “We expect mid-teens earnings growth to resume starting in FY2024,” said the note. Growth was led by steady India and EM business in the December quarter.
(Disclaimer: The views/suggestions/advice expressed here in this article are solely by investment experts. Zee Business suggests its readers to consult with their investment advisers before making any financial decision.)
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
PM Modi has invested in this post office scheme; know his total worth as per Lok Sabha elections 2024 affidavit
SRH vs GT IPL 2024 Ticket Booking Online: Where and how to buy SRH vs GT tickets online - Check IPL Match 66 ticket price, other details
Top 7 SWP Mutual Funds: Rs 50 lakh investment, Rs 70K monthly pension for 10 years, and Rs 42.30 lakh balance value; know more details
Gold and Silver rate today (May 13, 2024): Precious metal under pressure; yellow metal near Rs 72,400, white metal above Rs 84,600
SIP Returns: How Rs 3,000, 5,000, and Rs 10,000 SIPs can help you build retirement corpus of Rs 1.06 cr, Rs 1.77 cr, and Rs 3.53 cr
TBO Tek IPO Listing LIVE Update: Bumper Debut! Share list at 55% premium - Buy, sell or hold? Check Anil Singhvi's view
09:44 AM IST